XO1's Series A Round

XO1 raised a round of funding on June 17, 2013. Investors include Medicxi Ventures.

XO1 is a biotechnology company formed specifically to develop ichorcumab. It is a virtual company, with no offices or laboratory space, and operates by engaging high quality contract research and deve…

Articles about XO1's Series A Round: